Orient EuroPharma Co., Ltd. (TPEX: 4120)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
48.50
-0.40 (-0.82%)
Sep 11, 2024, 11:16 AM CST
10.35%
Market Cap 4.24B
Revenue (ttm) 4.50B
Net Income (ttm) 144.76M
Shares Out 86.75M
EPS (ttm) 1.67
PE Ratio 29.30
Forward PE n/a
Dividend 1.00 (2.04%)
Ex-Dividend Date Jul 19, 2024
Volume 10,418
Open 48.60
Previous Close 48.90
Day's Range 48.50 - 48.60
52-Week Range 36.70 - 55.90
Beta 0.42
Analysts n/a
Price Target n/a
Earnings Date Nov 8, 2024

About Orient EuroPharma

Orient EuroPharma Co., Ltd., a pharmaceutical company, develops and manufactures drugs worldwide. Its prescription medicines include cardiovascular, metabolism, neurology, obstetrics and gynecology, respiratory, andrology, immunology, antibiotic, and anti-cancer drugs. The company also provides nutrition and baby care products, such as milk and nutritional supplements under the Karihome, Babecare, and Ostricare brands; and healthcare supplements, such as thermal water for the treatment of oral and periodontal diseases under the Buccotherm name.... [Read more]

Sector Healthcare
Founded 1982
Employees 339
Stock Exchange Taipei Exchange
Ticker Symbol 4120
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.